Egetis Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	145.7	351	303.3	127.7	144	287.85
Cash & Short-Term Investments	145.7	351	303.3	127.7	144	287.85
Cash Growth	12.16%	15.73%	137.51%	-11.32%	-49.97%	12.84%
Accounts Receivable	35.1	15.5	28.2	3.8	3.5	3.88
Other Receivables	7.9	8.1	8.4	6.7	3.3	3.58
Receivables	43	23.6	36.6	10.5	6.8	7.46
Inventory	1.1	1	0.7	0.6	0.7	3.14
Prepaid Expenses	8.6	4.1	4.4	8.2	1.3	1.42
Other Current Assets	-0.1	0.4	0.9	0.4	0.1	0
Total Current Assets	198.3	380.1	345.9	147.4	152.9	299.87
Property, Plant & Equipment	10.4	2.6	4.4	2.7	4.3	4.74
Long-Term Investments	0.8	0.8	0.8	0.8	0.8	-
Other Intangible Assets	2.4	3.2	4.3	5.4	6.5	7.57
Long-Term Deferred Tax Assets	1.9	0.6	-	-	-	-
Long-Term Deferred Charges	381.2	404.8	404.8	404.8	404.8	404.82
Other Long-Term Assets	0.1	0.2	-	-	-	-
Total Assets	595.1	792.3	760.2	561.1	569.3	717
Accounts Payable	37.9	25.7	28.7	20	4.6	15.61
Accrued Expenses	167.9	131	47.2	12.7	5.3	3.51
Current Portion of Long-Term Debt	31.4	30.1	5.2	-	-	-
Current Portion of Leases	-	2.5	2.2	1.6	1.5	1.14
Current Income Taxes Payable	-	0.2	0.1	-	-	-
Other Current Liabilities	10.2	14.7	20.5	15.1	27.8	49.88
Total Current Liabilities	247.4	204.2	103.9	49.4	39.2	70.14
Long-Term Debt	54.3	84.1	103.4	-	-	-
Long-Term Leases	6.3	0.4	2.2	1.1	2.7	3.53
Long-Term Deferred Tax Liabilities	1.9	0.5	-	-	-	-
Other Long-Term Liabilities	7.7	10.2	5.1	4.4	0.4	12.61
Total Liabilities	317.6	299.4	214.6	54.9	42.3	86.28
Common Stock	20.4	20.4	15.4	11.3	8.7	8.69
Additional Paid-In Capital	2,058	2,058	1,780	1,428	1,263	1,263
Retained Earnings	-1,834	-1,610	-1,267	-939.6	-745.8	-641.25
Comprehensive Income & Other	33.3	24.9	16.7	6.1	1.3	0.45
Shareholders' Equity	277.5	492.9	545.6	506.2	527	630.72
Total Liabilities & Equity	595.1	792.3	760.2	561.1	569.3	717
Total Debt	92	117.1	113	2.7	4.2	4.67
Net Cash (Debt)	53.7	233.9	190.3	125	139.8	283.18
Net Cash Growth	203.39%	22.91%	52.24%	-10.59%	-50.63%	11.06%
Net Cash Per Share	0.15	0.75	0.73	0.64	0.78	4.20
Filing Date Shares Outstanding	359.24	359.24	292.57	214.59	165.07	165.07
Total Common Shares Outstanding	359.24	359.24	292.57	214.59	165.07	165.07
Working Capital	-49.1	175.9	242	98	113.7	229.73
Book Value Per Share	0.77	1.37	1.86	2.36	3.19	3.82
Tangible Book Value	275.1	489.7	541.3	500.8	520.5	623.15
Tangible Book Value Per Share	0.77	1.36	1.85	2.33	3.15	3.78
Machinery	-	0.1	0.3	0.2	0.3	0.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.